Dr. Curtin is a physician and post-viral illness expert specializing in myalgic encephalomyelitis (ME/CFS) and its comorbidities. She is a member of the ME/CFS Clinician Coalition and co-authored the official clinical guidance for ME/CFS. Dr. Curtin has a personal understanding of the difficulties Long COVID patients experience as she is a mostly recovered ME/CFS patient herself. She understands the urgency that is necessary to understand Long COVID and bring her clinical expertise to the millions of patients currently seeking help.
Dr. Kellogg’s experience with complex illness led him to pioneer technology for molecular profiling using self-collected blood microsamples as a scientist at Stanford University. This allows for a better understanding of health fluctuations and the impacts of health interventions. When combined with wearable sensors and symptom tracking, this technology allows for real-time health monitoring and pattern discovery with unprecedented resolution.
Dr. Snyder is the head of Stanford’s Healthcare Innovation Lab, co-founder of multiple companies, and a pioneer in the use of wearable devices and app-collected data to understand, detect, and even predict changes in general health and disease. This technology allowed him to predict, detect, and correct his own post-viral diabetes. It is this wearable technology and health-tracking capabilities that play a key role in the treatment process here at RTHM.
Dr. Malcolm is an internal medicine physician. He started treating Long COVID in March 2020 and has treated over 100 patients with this illness (including patients with post vaccine issues). Prior to RTHM, he was a primary care doctor with One Medical, where he saw how technology can advance medical care. He also served as a doctor at the Haight Ashbury Free Clinic, the oldest free clinic in the United States, and understands the importance of access to care. He believes that RTHM has the approach to cure Long COVID. He is excited to dedicate himself fully to this terrible illness.
Melanie is an experienced Medical Assistant with a degree in Neuroscience from University College Dublin, Ireland. This knowledge base, paired with her own life-altering complex illness, gives her a strong understanding and unique perspective of how illnesses such as Long COVID can affect a person as a whole, mind and body. Since March 2020, she has chosen to work on the COVID front lines; starting in the ICU, then transitioning to school Isolation Rooms. Now, she is excited to team up with RTHM against Long COVID in search of a solution.
Dr. Rose is a physician-scientist who is board certified in Physical Medicine and Rehabilitation and Spinal Cord Injury Medicine. She also has training in functional medicine and a PhD in Population Health Sciences. She has personal experience with complex illness and has a long-standing interest on how life exposures affect health. Prior to RTHM she was a researcher at Stanford where she led a project on the use of longitudinal big data which includes deep molecular profiling and wearable sensors technologies to advance health. She is excited bring her clinical and research expertise to RTHM to serve patients with Long COVID.
Cathy is a nurse practitioner with a long-standing history of managing complex illnesses. She has managed COVID patients since March 2020. Before the pandemic, she managed a post-acute care population where many patients had multiple complex comorbidities. She also served as a primary care provider at Rock Hill Community Based Outpatient Clinic, meeting local veterans’ needs. She brings her experience to RTHM with a passion for helping better understand and manage the effects of long-haul COVID symptoms.
Monique is a Medical Assistant with 12 years of experience in Internal medicine, complex illnesses, and more. She has volunteered with many local communities during the pandemic. Her passion and interest for complex illnesses has led her to work for RTHM.
Jamie graduated from the University of California Santa Cruz, earning a degree in health science. After graduating, he worked at a skilled nursing facility for two years, as a medical assistant in a Rheumatology practice, and spent the last three years working at a family practice. While living in Santa Cruz, he volunteered at a free clinic that provided primary care and discounted medication to the community. He knows health care can be difficult to traverse and has a passion for assisting individuals in navigating it. He loves spending time outdoors with his partner and their dog Nala in his off time.
Kendra is an experienced Nationally Certified Medical Assistant with over 14 years in the field. She holds a Master’s degree in Psychology with a concentration in Health Psychology. She is currently a graduate student in Clinical Mental Health Counseling at Walden University and a medical student at Washington University of Health Sciences. She has special knowledge of living with a chronic illness such as Long COVID and can empathize with the patients that we see. Kendra also worked on the frontlines during March 2020 in an urgent care facility. Her dedication to patient care is what landed her at RTHM.
Jessi is a recent Biology graduate from Florida A&M University. She has currently been a CMA for about three years now with her initial experience being pain management, where she has gained useful insight on the complexities of pain. In her pastimes, she tends to her garden and loves to cook different foods from different parts of the world. She's excited to work with RTHM and aid in the treatment of long-term COVID.
Cecil is an experienced CMA and Wellness Coach with a degree in Molecular Environmental Biology with an emphasis in Environment and Human Health from UC Berkeley. He has contributed and expanded his clinical knowledge in fields such as Urgent Care, Primary Care, Holistic Care and Regenerative medicine. With a shared vision, Cecil has joined RTHM in the quest towards providing quality healthcare through root cause analysis and balancing proactive and reactive care to guide patients towards optimal and healthy lifestyles.
Dr. Yael is the director of research and development for Biomarker discovery & Multiplex assays at RTHM. She has previously been at the Human Immune Monitoring Center (HIMC), Stanford University School of Medicine, for the past 15 years managing the immunoassay team, operations, and development of multiplex assays, as well as database and customer support. She led the research and testing of unique sample matrices and microsampling protocols.
Ian has drawn on his past as a cancer survivor for inspiration through his career as an analytical chemist. Bringing a wealth of chemistry knowledge to the team, he leads our mass spectrometry efforts and operations within the laboratory. His focus on targeted metabolomics will aid the ongoing effort to identify the chemical signatures of long covid and, ultimately, new targets for possible treatments. Ian enjoys racing sailboats and spending time on the water in his spare time.
Jimena is currently an undergraduate student in biomedical engineering at San Jose State University. She is interested in using the application of engineering principles and design concepts in medicine and biology for healthcare purposes. At RTHM, Jimena assists Yael and Ian with projects and operations within the laboratory.
Zachary is a former educator that studied Mathematics at the University of California, Berkeley. While studying in college he developed a keen interest for nutrition; specifically, the effect food has on different individuals and various societies as a whole. With a strong belief that nutrition can reduce the intensity of, or even eliminate a number of physical and mental health issues entirely, he has come to RTHM to help solve problems that are more complex than just a nutritional change.
Jille is a graduate student in Artificial Intelligence at the University of Amsterdam. He has worked at numerous healthcare-related companies during his studies and with the biggest hospital in the Netherlands, using AI to identify novel markers in hematology data for certain diseases. He is currently helping RTHM with data-related tasks and finding better and more efficient ways to treat patients through machine learning.
Alice studies Mathematics and Computational & Neural Systems at the California Institute of Technology. She has worked hands-on with big data for predicting the most elusive cancers, refined mission-critical multi-omic diagnostic pipelines, and designed and pitched global-scale solutions to the covid crisis. She cultivates a passion for the multi-disciplinary work of drawing insights from disparate streams of data, and turning those insights into impacts. At RTHM, she wrangles data and uses modern machine learning techniques to improve patients’ lives.
Eduardo comes to RTHM from his MBA at MIT, where he is responsible for solidifying product vision, commercializing our services, and operationalizing the business. At MIT, he founded his own social health network venture, leading a team to crowdsource treatments and insights for long covid as part of the MIT DHIVE incubator program. Before that, he held various positions leading cross-functional teams in finance, strategy, mergers & acquisitions, and product management in medical devices and pharmaceutical services for Cardinal Health.
Dr. Sonder is a computer engineer, physician and a patient. She has years of experience translating complicated medical requirements into functional software. Her broad experience allows her to create multi-disciplinary products, while considering the impact to the patient
Zuzanna is a graduate student in Human-Computer Interaction at Utrecht University. She also holds a degree in Management and AI and is pursuing a master's degree in Data-driven Design.
Zuzanna previously worked as a communication specialist and a data intelligence specialist in two well-known European startups.
At RTHM, she is responsible for web and product design, bringing patients and providers the best possible digital experience.
RTHM integrates remote clinical medicine and research with advanced molecular and digital measurement technologies to bring new diagnostics and treatments to patients faster, starting with Long COVID.